| EasyModeller: A graphical interface to MODELLER BK Kuntal, P Aparoy, P Reddanna BMC research notes 3, 1-5, 2010 | 263 | 2010 |
| Structure and ligand based drug design strategies in the development of novel 5-LOX inhibitors P Aparoy, K Kumar Reddy, P Reddanna Current medicinal chemistry 19 (22), 3763-3778, 2012 | 252 | 2012 |
| Evolutionary aspects of lipoxygenases and genetic diversity of human leukotriene signaling HD Horn T, Adel S, Schumann R, Sur S, Kakularam KR, Polamarasetty A, Redanna ... Prog Lipid Res. 57, 13–39, 2015 | 126 | 2015 |
| Free energy calculations to estimate ligand-binding affinities in structure-based drug design M Rami Reddy, C Ravikumar Reddy, R S Rathore, M D Erion, P Aparoy, ... Current pharmaceutical design 20 (20), 3323-3337, 2014 | 81 | 2014 |
| Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs RN Reddy, R Mutyala, P Aparoy, P Reddanna, MR Reddy Current pharmaceutical design 13 (34), 3505-3517, 2007 | 62 | 2007 |
| Homology modeling of 5-lipoxygenase and hints for better inhibitor design P Aparoy, RN Reddy, L Guruprasad, MR Reddy, P Reddanna Journal of Computer-Aided Molecular Design 22, 611-619, 2008 | 58 | 2008 |
| Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors NP Reddy, P Aparoy, TCM Reddy, C Achari, PR Sridhar, P Reddanna Bioorganic & medicinal chemistry 18 (16), 5807-5815, 2010 | 57 | 2010 |
| Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy … N Chaudhary, P Aparoy Journal of Biomolecular Structure and Dynamics 35 (4), 868-882, 2017 | 56 | 2017 |
| Exploration of binding site pattern in arachidonic acid metabolizing enzymes, Cyclooxygenases and Lipoxygenases KK Reddy, VK Vidya Rajan, A Gupta, P Aparoy, P Reddanna BMC research notes 8, 1-10, 2015 | 56 | 2015 |
| Kinetics and docking studies of a COX-2 inhibitor isolated from Terminalia bellerica fruits T Chandramohan Reddy, P Aparoy, N Kishore Babu, K Anil Kumar, ... Protein and Peptide Letters 17 (10), 1251-1257, 2010 | 51 | 2010 |
| Discovery and biological evaluation of novel 1, 4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase R Filosa, A Peduto, P Aparoy, AM Schaible, S Luderer, V Krauth, ... European Journal of Medicinal Chemistry 67, 269-279, 2013 | 50 | 2013 |
| Conversion of pro-inflammatory murine alox5 into an anti-inflammatory 15S-lipoxygenating enzyme by multiple mutations of sequence determinants K Hofheinz, KR Kakularam, S Adel, M Anton, A Polymarasetty, ... Archives of Biochemistry and Biophysics, 2012 | 38 | 2012 |
| MM-PBSA and per-residue decomposition energy studies on 7-Phenyl-imidazoquinolin-4 (5H)-one derivatives: Identification of crucial site points at microsomal prostaglandin E … A Gupta, N Chaudhary, P Aparoy International journal of biological macromolecules 119, 352-359, 2018 | 36 | 2018 |
| CoMFA and CoMSIA studies on 5-hydroxyindole-3-carboxylate derivatives as 5-lipoxygenase inhibitors: Generation of homology model and docking studies P Aparoy, GK Suresh, KK Reddy, P Reddanna Bioorganic & medicinal chemistry letters 21 (1), 456-462, 2011 | 31 | 2011 |
| Pharmacophore modeling and virtual screening for designing potential 5-Lipoxygenase inhibitors P Aparoy, KK Reddy, SK Kalangi, TC Reddy, P Reddanna Bioorganic & medicinal chemistry letters 20 (3), 1013-1018, 2010 | 30 | 2010 |
| The Augmenting Effects of Desolvation and Conformational Energy Terms on the Predictions of Docking Programs against mPGES-1 AP Ashish Gupta, Neha Chaudhary, Kumar Reddy Kakularam, Reddanna Pallu PLoS ONE 10 (8), e0134472, 2015 | 26 | 2015 |
| Application of per-residue energy decomposition to identify the set of amino acids critical for in silico prediction of COX-2 inhibitory activity N Chaudhary, P Aparoy Heliyon 6 (10), 2020 | 23 | 2020 |
| Computational analysis of R and S isoforms of 12-Lipoxygenases: Homology modeling and docking studies P Aparoy, T Leela, RN Reddy, P Reddanna Journal of Molecular Graphics and Modelling 27 (6), 744-750, 2009 | 18 | 2009 |
| Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies R Kulandaisamy, T Kushwaha, A Dalal, V Kumar, D Singh, K Baswal, ... Frontiers in Microbiology 13, 877813, 2022 | 17 | 2022 |
| Structure based drug design, synthesis and evaluation of 4-(benzyloxy)-1-phenylbut-2-yn-1-ol derivatives as 5-lipoxygenase inhibitors NP Reddy, TC Reddy, P Aparoy, C Achari, PR Sridhar, P Reddanna European journal of medicinal chemistry 47, 351-359, 2012 | 17 | 2012 |
Pallu ReddannaEmeritus ProfessorPatvirtintas el. paštas uohyd.ac.in
